发明名称 Arginine inactivation of viruses
摘要 The present invention pertains to methods of using arginine to inactivate or reduce the infectious titer of enveloped viruses potentially present in biological compositions produced by eukaryotic cells (such as a antibodies or other therapeutic proteins). In some embodiments, inactivation or reduction of viral titers by exposure to arginine is achieved in a neutral (pH ˜7) or near neutral (˜pH 6 to ˜pH 8) environment.
申请公布号 US8980610(B2) 申请公布日期 2015.03.17
申请号 US200913130540 申请日期 2009.11.20
申请人 Biogen Idec MA Inc. 发明人 Selvitelli Keith;McCue Justin
分类号 C12N7/06;C12N7/00;A61K39/21 主分类号 C12N7/06
代理机构 Sterne Kessler Goldstein & Fox P.L.L.C. 代理人 Sterne Kessler Goldstein & Fox P.L.L.C.
主权项 1. A method of inactivating or reducing the infectious titer of a retrovirus comprising contacting said virus with arginine, wherein said contacting occurs in a solution comprising at least about 0.2 M arginine and wherein said solution is at a pH above about 6.0.
地址 Cambridge MA US